flurbiprofen has been researched along with Local Neoplasm Recurrence in 6 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Excerpt | Relevance | Reference |
---|---|---|
" Flurbiprofen did not seem to alter the bioavailability of the chemotherapeutic agents." | 1.26 | Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. ( Bennett, A; Berstock, DA; Carroll, MA, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Sakamaki, K | 1 |
Watanabe, K | 1 |
Woo, T | 1 |
Masuda, M | 1 |
Bennett, A | 5 |
Berstock, DA | 2 |
Carroll, MA | 1 |
Houghton, J | 2 |
Leaper, DJ | 3 |
French, B | 1 |
Stamford, IF | 1 |
French, BT | 1 |
1 trial available for flurbiprofen and Local Neoplasm Recurrence
Article | Year |
---|---|
Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Flurbiprofen; Humans; Japan; Lun | 2020 |
5 other studies available for flurbiprofen and Local Neoplasm Recurrence
Article | Year |
---|---|
Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
Topics: Adenocarcinoma; Animals; Biological Availability; Body Weight; Drug Therapy, Combination; Female; Fl | 1982 |
Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
Topics: Adenocarcinoma; Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Mammary Neoplasms, Expe | 1980 |
Reduction by flurbiprofen of primary tumor growth and local metastasis formation in mice.
Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; | 1980 |
Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.
Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; | 1979 |
Breast cancer and prostaglandins: a new approach to treatment.
Topics: Animals; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Recurrence, Loc | 1979 |